Pritelivir Mesylate Patent Expiration
Pritelivir Mesylate was first introduced by Aicuris Anti-Infective Cures Ag
Pritelivir Mesylate Patents
Given below is the list of patents protecting Pritelivir Mesylate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Hovilpri | US9119786 | Crystalline N-[5-(Aminosulfonyl)-4-Methyl-1,3-Thiazol-2-Yl]-N-Methyl-2-[4-(2-Pyridinyl)Phenyl]Acetamide Mono Mesylate Monohydrate Having A Specific Particle Size Distribution Range And A Specific Surface Area Range For Use In Pharmaceutical Formulations | Sep 26, 2032 | Aicuris Anti-infect |
| Hovilpri | US9340535 | N-[5-(Aminosulfony1)-4-Methyl-1,3-Thiazol-2-Yl]-N-Methyl-2-[4-(2-Pyridinyl)Phenyl]Acetamide Mesylate Monohydrate | Sep 26, 2032 | Aicuris Anti-infect |
| Hovilpri | US9889124 | Crystalline N-[5-(Aminosulfonyl)-4-Methyl-1,3-Thiazol-2-Yl]-N-Methyl-2-[4-(2-Pyridinyl)Phenyl]Acetamide Mono Mesylate Monohydrate Having A Specific Particle Size Distribution Range And A Specific Surface Area Range For Use In Pharmaceutical Formulations | Sep 26, 2032 | Aicuris Anti-infect |
| Hovilpri | USRE49697 | Sep 26, 2032 | Aicuris Anti-infect | |
| Hovilpri | US8784887 | Pharmaceutical Preparation Of N-[5-(Aminosulfonyl)-4-Methyl-1,3-Thiazol-2-Yl]-N-Methyl-2-[4-(2-Pyridinyl)Phenyl]Acetamide | Jul 18, 2029 | Aicuris Anti-infect |
Pritelivir Mesylate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List